+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Age Related Macular Degeneration Drug"

Macular Degeneration Treatment Market Report 2025 - Product Thumbnail Image

Macular Degeneration Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
Dry Age-related Macular Degeneration (Dry-AMD) - Pipeline Insight, 2024 - Product Thumbnail Image

Dry Age-related Macular Degeneration (Dry-AMD) - Pipeline Insight, 2024

  • Clinical Trials
  • July 2024
  • 240 Pages
  • Global
From
Age Related Macular Degeneration - Pipeline Insight, 2024 - Product Thumbnail Image

Age Related Macular Degeneration - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Dry AMD - Pipeline Insight, 2024 - Product Thumbnail Image

Dry AMD - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
Wet Age-Related Macular Degeneration (Wet AMD) - Pipeline Insight, 2024 - Product Thumbnail Image

Wet Age-Related Macular Degeneration (Wet AMD) - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 240 Pages
  • Global
From
From
Wet Macular Degeneration - Pipeline Insight, 2024 - Product Thumbnail Image

Wet Macular Degeneration - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Macular Degeneration Pipeline Analysis Report - Product Thumbnail Image

Macular Degeneration Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
From
From
From
Loading Indicator

The Age Related Macular Degeneration (AMD) Drug market is a subset of the Optical Disorders Drugs market. AMD is a degenerative eye condition that affects the macula, the part of the eye responsible for central vision. AMD is the leading cause of vision loss in people over the age of 50. Treatment options for AMD include drugs, laser therapy, and surgery. Drugs used to treat AMD include anti-VEGF drugs, which block the growth of abnormal blood vessels in the eye, and corticosteroids, which reduce inflammation. These drugs are typically administered via intravitreal injections. The AMD Drug market is highly competitive, with a number of companies offering treatments. These include Regeneron Pharmaceuticals, Novartis, Allergan, and Roche. Show Less Read more